Expression of TLE3 by bone marrow stromal cells is regulated by canonical Wnt signaling  by Kokabu, Shoichiro et al.
FEBS Letters 588 (2014) 614–619journal homepage: www.FEBSLetters .orgExpression of TLE3 by bone marrow stromal cells is regulated
by canonical Wnt signaling0014-5793/$36.00  2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.12.031
Abbreviations: TLE, transducing-like enhancer of split; ALP, alkaline phospha-
tase; BMP, bone morphogenetic protein; OC, Osteocalcin; PPARc, proliferator-
activated receptor c; C/EBP, CCAAT/enhancer-binding protein; BMSC, bone marrow
stromal cell
⇑ Corresponding author at: Department of Oral and Maxillofacial Surgery, Faculty
of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi,
Saitama 350-0495, Japan. Fax: +81 49 294 2637.
E-mail addresses: kokabu2@saitama-med.ac.jp, kokabu2@gmail.com (S. Kokabu).Shoichiro Kokabu a,b,⇑, Tsuyoshi Sato a, Satoshi Ohte b, Yuichiro Enoki a, Masahiko Okubo a,
Naoki Hayashi a, Junya Nojima a, Sho Tsukamoto c, Yosuke Fukushima a, Yasuaki Sakata a,
Takenobu Katagiri c, Vicki Rosen b, Tetsuya Yoda a
aDepartment of Oral and Maxillofacial Surgery, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Saitama 350-0495, Japan
bDepartment of Developmental Biology, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115, USA
cDivision of Pathophysiology, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama 350-1241, Japan
a r t i c l e i n f oArticle history:
Received 24 October 2013
Revised 19 December 2013
Accepted 20 December 2013
Available online 17 January 2014
Edited by Zhijie Chang
Keywords:
Osteoblastogenesis
Osteoporosis
Wnt
Groucho
Transducing-like enhancer of split
Co-repressora b s t r a c t
Transducing-like enhancer of split 3 (TLE3), one of the Groucho/TLE family members, targets Runx2
transcription and suppresses osteoblast differentiation in bone marrow stromal cells (BMSCs). Here,
we identify Wnt responsive elements of the TLE3 promoter region through comparative genomic
and functional analyses and show that expression of TLE3 is increased by Wnt signaling, which is
important for osteoblast differentiation. We also demonstrated that TLE3 is able to suppress
canonical Wnt signaling in BMSCs. Taken together, our data suggest that induction of TLE3 by
Wnt signaling is part of a negative feedback loop active during osteoblast differentiation.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Several transcription factors have been shown to be critical forIn adults, bone is constantly remodeled through the coupled
processes of bone formation by osteoblasts and bone resorption
by osteoclasts. Osteoclasts are derived from hematopoietic stem
cell precursors of the monocyte/macrophage lineage located in
the blood and bone marrow [1], while osteoblasts originate from
bone marrow stromal cells (BMSC)s [2]. BMSCs are a multipotent
cell type that can give rise not only to osteoblasts, but also to a
range of other cell types including adipocytes, chondrocytes, and
myoblasts [3]. BMSCs have been shown to acquire the osteoblast
phenotype in culture [4] and form bone in vivo after implantation
in diffusion chambers [5,6]. We previously reported that W20-17, a
cell line derived from adult mouse bone marrow responds to BMP2
by differentiating into osteoblast-like cells [7,8].osteoblast differentiation, including Runx2 [9], Osterix [10], Dlx2
[11], and Dlx5 [12]. In particular, Runx2, a Runt domain-containing
transcription factor, is indispensable for osteoblast differentiation
during both endochondral and intramembranous ossiﬁcation
[9,13,14], where it appears to be the target of Twist1 [15], Hand2
(heat and neural crest derivatives expressed 2) [16], ZFP521
(zinc-ﬁnger protein 521) [17], STAT1 (signal transducer and activa-
tor of transcription 1) [18], Schnurri3 [19], Gli3 [20], Hoxa2 [21],
and the Hes (Hairy an Enhancer of Split) and Hey (Hes-related with
YRPW motif) protein [22,23].
Groucho/TLE are transcriptional co-repressor proteins that do
not bind DNA directly, but are recruited by a diverse proﬁle of
transcription factors, including members of the Hes, Runx2, Nkx,
Pax, cMyc and TCF/LEF, which is downstream effector of Wnt
signaling [24].
We recently reported that transducin-like enhancer of split 3
(TLE3), one of the Groucho/TLE family members, targets Runx2
transcription and suppresses osteoblast differentiation in BMSCs
[25]. Here, we identify Wnt responsive elements of TLE3
promoter region though comparative genomic and functional
analyses and show that expression of TLE3 is increased by Wnt
signaling. Since TLE3 has been shown to suppress Wnt signaling,
S. Kokabu et al. / FEBS Letters 588 (2014) 614–619 615we suggest that this induction of TLE3 by Wnt is part of a
modulatory mechanism by which Wnt signaling controls osteo-
blast differentiation.
2. Materials and methods
2.1. In silico experiments
DNA sequences were aligned using BLASTIN [26] Version
2.2.26 ± or ECR Brower [27] through the respective online servers
or locally using MUSCLE in MEGA5 software [28]. For identiﬁcation
of transcription factor binding sites, DNA sequences were ﬁrst
aligned using zPicture [29] then transferred to rVista 2.0 [30].
Amino-acid homology between human and mouse TLE3 were
determined by using Protein–protein BLAST (blastp) analysis.
2.2. Plasmids
Plasmids encoding constitutively active b-catenin has been
described previously [31]. Mouse C/EBPa (plasmid ID;
MmCD00314721), mouse C/EBPb (plasmid ID; MmCD00297423)
were provided by DF/HCC DNA Resource Core (BCMP Department
240 Longwood Ave. Boston, MA 02115). Mouse TLE3 (accession
number NM_001083927) and Mouse PPARc (accession number
NM_011146.3) were obtained by a standard RT-PCR technique
using PrimeSTAR HS DNA polymerase (TaKaRa, Ohtsu, Japan) [32]
and cloned into pcDNA3.1/V5 (Invitrogen) or a pcDEF3 expression
vector [33]. Mouse Runx2 [9] was kindly provided by Dr. Toshihisa
Komori (Nagasaki University). TLE3 (3.0), TLE3 (2.0), TLE3 (1.0),
and TLE3 (0.5)-luciferase reporter vector were respectively con-
structed by subcloning from 3.0, 2.0, 1.0, and 0.5 kbp fragment of
the 50 ﬂanking region of the mouse TLE3 gene into the pGL4,14
basic luciferase reporter vector. Super TOP ﬂash-luciferase reporter
vector [31] was kindly provided by Dr. Randall Moon. All of the
ﬁnal constructs were conﬁrmed by sequencing.
2.3. Cell culture and transfection
W-20-17 cells, C3H10T1/2 cells, C2C12cells, and MC3T3-E1
cells were cultured and maintained as described previously
[7,34–36]. 3T3-L1 cells from ATCC (American Type Culture Collec-
tion) were grown in Dulbecco’s modiﬁed Eagle’s (DMEM) medium
containing 10% fetal bovine serum (FBS). Primary BMSCs were col-
lected from femurs and tibias of 6-week old wild-type C57BL/6J
mice. After epiphyses were removed, bone was ﬂushed with
15 ml aMEMmedium using a 20 ml syringe ﬁtted with a 23-gauge
needle. Flushed bone marrow cells were cultured with aMEM
medium containing 15% FBS for 4 days [8]. Cells were treated with
100 ng/ml rhWnt3a (R&D Systems). Wnt3a conditioned medium
were collected from L-M (TK-) cells (ATCC CCL-1.3™) according
to the manufacturer’s instructions (American Type Culture Collec-
tion). Cells were transfected with plasmids using Lipofectamine
2000 (Invitrogen) [37,38].
2.4. Luciferase assays
Luciferase assays were performed using TLE3 (3.0)-luc, TLE3
(2.0)-luc, TLE3 (1.0)-luc, TLE3 (0.5)-luc, Super Top ﬂash-luc, or
phRL-SV40 (Promega) with the Dual-Glo Luciferase Assay System
(Promega) [39,40].
2.5. Western blot analysis
The following antibodies were used for western blot analysis:
anti-TLE3 polyclonal antibody (M-201; sc-9124) (Santa Cruz),anti-b-actin mouse monoclonal antibody (Sigma Aldrich Chemi-
cals). The target proteins were detected using a horseradish
peroxidase-conjugated anti-mouse or anti-rabbit IgG antibody
(Cell Signaling).
2.6. Chromatin Immunoprecipitation assay
Chromatin Immunoprecipitation (ChIP) was performed with a
ChIP assay kit (Upstate/Millipore) according to the manufacturer’s
instructions with minor modiﬁcations. Brieﬂy, primary bone mar-
row stromal cells were treated with or without Wnt3a conditioned
medium for 5 h. Cells were treated with 1% formaldehyde (Sigma)
for 10 min at 37 C for cross-link DNA to proteins. Cells were
washed with cold PBS containing proteinase inhibitor mixture
(Thermo Fisher Scientiﬁc) and collected and pelleted at
1000 rpm. Cells pellets were resuspended in SDS lysis buffer and
incubated on ice for 10 min. Samples were sheared on ice using a
Misonix Sonicator 3000 (Mixonix, Farmingdale, NY) and resolved
on agarose gels to conﬁrm that the average fragment sizes were
between 200 and 500 bp. 20 ll of the sonicated samples were
saved for total DNA loading controls. Samples were diluted with
ChiP dilution buffer and precleaned with salmon sperm DNA/Pro-
tein A-agarose, 50% slurry. Precleaned chromatin was incubated
with 2 mg of antibody at 4 C for 16 h. Antibodies used were anti
b-catenin (#9562) (Cell Signaling), and ChromPure Rabbit IgG
whole molecule (Jackson ImmunoResearch Laboratories, Balti-
more) as a control. Chromatin-antibody complexes were recovered
by sperm DNA/protein A-agarose, 50% slurry, and eluted with 1%
SDS and 0.1 M NaHCO3 mixed buffer. Cross-links were reversed
with the addition of 0.2 M NaCl at 65 C for 5 h. The samples were
then treated in 0.01 M EDTA, 0.04 M Tris–Cl, pH6.8 with 30 mg/ml
proteinase K at 37 C for 1 h. DNA was recovered phenol/chloro-
form extraction and ethanol precipitation. The puriﬁed DNA was
analyzed by PCR using the following primers. TLE3 promoter sense
a; AAT TGG GCT GCT TTG CAA CC and TLE3 promoter anti-sense b;
GAG AGC AGT TCC AAA TAG GG.
2.7. Reverse transcription and quantitative PCR analysis
Total RNA was isolated from W-20-17 cells, primary BMSCs,
C3H10T1/2 cells, C2C12cells, MC3T3-E1 cells, and 3T3-L1 using
Trizol (Invitrogen) and then reverse-transcribed into cDNA using
Transcriptor First Strand cDNA Synthesis Kit (Roche). The cDNA
was ampliﬁed by PCR using speciﬁc primers for murine TLE3 (for-
ward, agtctcgcctccattcctg; reverse, catctgcccatcagcactc), murine
Axin2 (forward, gagagtgagcggcagagc; reverse, cggctgactcgttctcct),
and murine b-actin (forward, aaggccaaccgtgaaaagat; reverse,
gtggtacgaccagaggcatac). SYBR green-based quantitative real-time
PCR was performed in 96-well plate using Fast Start Universal
SYBR Green Master (Roche) with iCycler Multicolor Real-Time
PCR Detection system (BIO-RAD). Values were normalized to
b-actin using the 2DDCt method [41].
2.8. Statistical analysis
Comparisons were made using an unpaired Student’s t-test; the
results are shown as means ± S.D. Statistical signiﬁcance is
indicated as ⁄P < 0.05 and ⁄⁄P < 0.01.
3. Results
3.1. Conservation analysis of the TLE3 upstream region
To identify the mouse TLE3 promoter, we used ECR (Evolution-
ally Conserved Region) Browser [27,42] to analyze the regions of
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start site between Mus musculus and Homo sapiense. This revealed
a high level of nucleotide identity (P77% across sliding 350 nt win-
dow) in the approximately 2.5 kb region proximal to the annotated
transcription start site ofM. musculus TLE3. We also noted a poorly
conserved region is present in between approximately 2.5 and
2.8 kb fragment of the 50 ﬂanking region (Fig. 1).
3.2. ECR contains putative binding site of transcriptional factors, which
may regulates osteoblast differentiation
Based on the comparative analysis of ECR between M. musculus
and H. sapiense, we predicted that the M. musculus TLE3 promoter
would reside within the conserved region which is 2.5 kb fragment
of the 50 ﬂanking region of murine tle3 gene. rVista2.0 [30] analysis
of this 2.5 kbp region allowed us to identify binding sites for tran-
scription factors that may regulate adipogenesis and/or osteoblas-
togenesis, such as TCF/LEF and C/EBPs [43–45]. We next generated
the TLE3 (3.0) luciferase reporter construct containing this 2.5 kbp
ECR conserved fragment of the 50 ﬂanking region of murine tle3
gene and examined the effect of Wnt3a, C/EBPa, or C/EBPb,
predicted to regulate promoter of TLE3 by rVista2.0 analysis, on
this reporter activity. We also examined the promoter regulating
effects of Runx2 and PPARc, which are also known to regulate
osteoblast and/or adipocyte differentiation [9,46]. These experi-
ments showed that only Wnt3a increased the activity of TLE3
(3.0)-luc in W20-17 cells (Fig. 2A).
3.3. Wnt/b-catenin signaling regulate TLE3 expression in bone marrow
stromal cells
To identify Wnt response elements in TLE3 promoter region,
we created the deleted TLE3 promoter-luc reporter vectors
such as TLE3 (3.0)-luc, TLE3 (2.0)-luc, TLE3 (1.0)-luc, or TLE3
(0.5)-luc, containing 3.0, 2.0, 1.0, or 0.5 kbp fragment of the
50 ﬂanking region of the mouse tle3 gene respectively. Wnt3aFig. 1. Conservation analysis of the TLE3 upstream region. Conservation of the genom
from ECR Browser aligning the regions upstream of the TLE3 transcription start site bet
350 nt window [29]. This revealed a highly conserved 2.5 kb region proximal to the ann
A B
Fig. 2. ECR contains putative binding site of transcriptional factors, which may re
vector, Runx2, Wnt3a, PPARc, C/EBPa, or C/EBPb along with TLE3 (3.0) luc (A). (B and C) W
luc activity. W20-17 cells were co-transfected with pGL4.14 empty vector as control, TL
Wnt3a (B), or along with empty vector or constitutively active b-catenin (C). Luciferaseand constitutively active b-catenin increased luc activity for each
of these fragments (Fig. 2B and C), suggesting that Wnt respon-
sive elements reside from positions 0.5 kbp to 0 in 50 ﬂanking
region of mouse tle3 gene, an area that shares 91% homology with
that of human genomic tle3 DNA and where we are able to
identify three putative TCF/LEFs binding elements (Fig. 3A). Using
a chromatin immmunoprecipitation assay, we were able to show
binding of b-catenin anti-body at these sites in response to
Wnt3a (Fig. 3B and C). Taken together these data suggest that
Wnt/b-catenin signaling directly stimulates TLE3 promoter activ-
ity. When we examined the expression levels of endogenous TLE3
in W20-17cells and primary BMSCs, we found that TLE3 mRNA in
W20-17 cells and primary BMSCs and protein in W20-17 cells
were stimulated by Wnt3a treatment, further supporting our
hypothesis that Wnt/b-catenin signaling regulates not only TLE3
promoter activity but also endogenous TLE3 expression in BMSCs
(Fig. 4A and B, and Supple Fig. 1).
3.4. TLE3 suppresses Wnt/b-catenin signaling
It has been reported that Groucho/TLE family members
including TLE3 repressed TCF/LEF transcription downstream of
canonical Wnt signaling [47]. Consistent with these ﬁndings,
over-expression of TLE3 completely repressed canonical Wnt
signaling as assessed by Super-top ﬂash reporter activity in
W20-17 cells (Fig. 4C).
4. Discussion
In this paper we report that canonical Wnt signaling directly in-
duces TLE3 expression, providing experimental support for the
idea that induction of TLE3 by Wnt signaling is part of a negative
feedback loop active during osteoblast differentiation.
Members of Groucho/TLE family are present in all or almost all
metazoans [48–52]. While the Drosophila genome encodes a single
Gro, the human and mouse genomes encode each four members,ic region upstream of TLE3 inM. musculus and H. sapiense. Composite image adapted
ween M. musculus and H. sapiense. Threshold was set to 77% identity across sliding
otated transcription start site of M. musculus TLE3.
C
gulates osteoblast differentiation. W20-17 cells were co-transfected with empty
nt3a treatment or over-expression of constitutively active b-catenin increased TLE3
E3 (3.0)-luc, TLE3 (2.0)-luc, TLE3 (1.0)-luc, or TLE3 (0.5)-luc along with or without
activity was determined on day 1 (C). Values are mean ± SD (n = 3).
A B C
Fig. 3. TLE3 promoter activity is increased byWnt/b-catenin signaling. Nucleotide sequences from500 to 0 of 50 ﬂanking region of murine TLE3. Bold type and under lines
(a and b) indicated putative TCF/LEF binding elements and primer sites for ChIP assays (A). Schematic of b-catenin/TCF/LEF complex regulating promoter activity (B). ChIP
assays demonstrate that b-catenin binds to the promoter region of TLE3 in response to Wnt3a stimulation in primary BMSCs (C).
A B C
Fig. 4. Wnt/b-catenin signaling increases TLE3 expression. (A and B) W20-17 cells were treated with or without recombinant human Wnt3a. mRNA levels (A) and protein
levels (B) of TLE3 were determined on day1(A) and day2(B) respectively. W20-17 cells were co-transfected with empty vector or TLE3 along with Super-Top ﬂash luc reporter
and constitutive active b-catenin. Luciferase activity was determined on day 1 (C). Values are mean ± SD (n = 3). ⁄⁄, P < 0.01 in comparison with a control.
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mouse [49,53]. TLE and Gro have often been used interchangeably
for vertebrate orthologs in the literature and in sequence databases
[24]. Indeed, mouse and human TLE3 share at least 97% amino acid
identity [24].
Groucho/TLE family proteins play critical roles in a wide array
of developmental and cellular pathways [54]. TLE3 is expressed
by placenta [55], brown and white adipose tissue [56,57], and bone
marrow [25]. In addition, expression of TLE3 is known to increase
with adipocyte differentiation [56]. In this report we identiﬁed
Wnt responsive elements in the mouse tle3 promoter region by
comparing mouse ECR with human, and demonstrated that Wnt
signaling regulates TLE3 expression in BMSCs.
DKK1 is a canonical Wnt antagonist and thus DKK1 hetero-
zygous mouse are a genetic model of increased canonical Wnt
signaling [58]. When we examined DKK1 heterozygous mice,
TLE3 mRNA levels in BMSCs from DKK1 heterozygous mice were
elevated in comparison to wild-type littermates (data not shown).
This ﬁnding suggests that the regulation of TLE3 by Wnt/b-catenin
signaling occurs in BMSCs in vivo.
The responsiveness to Wnt/b-catenin signaling may vary in
each cell type to regulate endogenous TLE3 expression because
Wnt3a treatment failed to increase TLE3 expression in C2C12
myoblasts, MC3T3-E1 pre-osteoblasts, or 3T3-L1 pre-adipocytes
in contrast to W20-17 cells and C3H10T1/2 cells (Fig. 4C, Supple
Fig. 2 and 3). These differences may be based on the co-factors that
regulate TLE3 expression and/or epigenetic regulation. Clariﬁcation
of these differences must be important to understand the
physiological role of TLE3 in BMSCs.We also demonstrated that TLE3 is able to suppress canonical
Wnt signaling in BMSCs (Fig. 4C). This repression of Wnt signaling
by TLE3 may be part of the mechanism, along with suppression of
Runx2, by which TLE suppresses of osteoblast differentiation
[25,44]. The importance of canonical Wnt signaling in bone is well
documented and in general, increasing canonical Wnt signaling
correlates with enhanced bone formation through increased differ-
entiation and maturation of osteoblasts [59]. In this paper we
showed that canonical Wnt signaling induces the expression of
TLE3, which suppresses osteoblast differentiation of BMSCs. There-
fore, development of agents that reduce the expression of TLE3
may provide an additional beneﬁt to antiresorptive therapies that
block osteoclast activity as a way of stabilizing bone architecture.
Recent data on the importance of continuous bone remodeling as
a means to maintain the material and structural strength of bone
caution against the overuse of antiresorptives as they may allow
for accumulation of micro damage in bone and ultimately lead to
fracture in some patients [60]. Thus the development of new effec-
tive therapies that target enhancing bone formation by stimulating
osteoblast differentiation is required.
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